Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-758
Closed -$3K 2531
2025
Q4
$3K Buy
+758
New +$3.88K ﹤0.01% 2330
2025
Q3
Sell
-1
Closed 2524
2025
Q2
$0 Hold
1
﹤0.01% 2432
2025
Q1
$0 Buy
+1
New +$3 ﹤0.01% 2492

Bessemer Group's CVAC Position: Q1 2026 in Review

Bessemer Group sold out of CureVac (CVAC) in Q1 2026, closing a stake of 758 shares — an estimated $3K sold.

Bessemer Group first reported a position in CVAC in Q1 2025 and held it in 3 quarters. The position peaked at $3K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Bessemer Group reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Bessemer Group sold 758 CureVac shares in Q1 2026, an estimated $3K.
  • Bessemer Group first reported a position in CureVac in Q1 2025 and held it in 3 quarters.
  • Bessemer Group's CureVac position peaked at $3K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.